Orion Oyj

General ticker "ORINF" information:

  • Sector: Health Care
  • Industry: Drug Manufacturers - General
  • Capitalization: $11.5B (TTM average)

Orion Oyj follows the US Stock Market performance with the rate: 30.6%.

Estimated limits based on current volatility of 0.0%: low 92.05$, high 92.05$

Factors to consider:

  • Company pays dividends (annually): last record date 2026-03-26, amount 1.04$ (Y1.13%)
  • Earnings for 18 months up through Q2 (+1 year) exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [37.71$, 53.68$]
  • 2025-12-31 to 2026-12-31 estimated range: [42.16$, 59.14$]

Financial Metrics affecting the ORINF estimates:

  • Positive: with PPE of 19.3 at the end of fiscal year the price was neutral
  • Positive: 22.58 < Operating profit margin, % of 27.01
  • Positive: 2.37 < Operating cash flow per share per price, % of 4.45
  • Positive: 58.56 < Shareholder equity ratio, % of 61.69 <= 69.38
  • Positive: Industry inventory ratio change (median), % of -1.32 <= -0.92
  • Positive: 7.15 < Industry operating cash flow per share per price (median), % of 7.82
  • Positive: 5.07 < Industry earnings per price (median), % of 6.17
  • Positive: -2.60 < Investing cash flow per share per price, % of -1.29
  • Positive: Interest expense per share per price, % of 0.12 <= 0.33

Similar symbols

Short-term ORINF quotes

Long-term ORINF plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue €1,189.60MM €1,542.40MM €1,889.50MM
Operating Expenses €914.70MM €1,125.80MM €1,260.50MM
Operating Income €274.90MM €416.60MM €629.00MM
Non-Operating Income €-3.00MM €-3.50MM €-1.20MM
Interest Expense €5.20MM €7.60MM €8.20MM
R&D Expense €126.90MM €179.60MM €210.40MM
Income(Loss) €271.90MM €413.10MM €627.80MM
Taxes €55.10MM €0.00MM €127.50MM
Net Income(Loss)* €216.80MM €329.90MM €500.30MM
Stockholders Equity €890.10MM €1,005.00MM €1,284.50MM
Inventory €362.20MM €418.60MM €456.30MM
Assets €1,438.60MM €1,629.10MM €2,009.90MM
Operating Cash Flow €119.00MM €293.40MM €316.80MM
Capital expenditure €116.80MM €86.90MM €97.60MM
Investing Cash Flow €-108.40MM €-85.20MM €-98.60MM
Financing Cash Flow €-243.20MM €-108.80MM €-263.60MM
Earnings Per Share** €1.54 €2.34 €3.56

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.